The older cancer survivor

Critical Reviews in Oncology/Hematology

Volumn 60, Issue 2, 2006, Pages 131-143

  Rao, Arati V ^a   Demark Wahnefried, Wendy ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Elderly; Sequelae; Survivor

Indexed keywords

ANASTROZOLE; ANTHRACYCLINE DERIVATIVE; ANTIANDROGEN; ANTINEMATODAL AGENT; AROMATASE INHIBITOR; CARBOPLATIN; CISPLATIN; OXALIPLATIN; STEROID; TAMOXIFEN; TRASTUZUMAB;

ANEMIA; BODY COMPOSITION; BODY WEIGHT; BONE NECROSIS; BREAST CANCER; CANCER; CANCER SURVIVOR; CARDIOTOXICITY; CATARACT; COMORBIDITY; DEEP VEIN THROMBOSIS; DEPRESSION; DIET THERAPY; EXERCISE; FOLLOW UP; FUNCTIONAL STATUS; GENETIC SCREENING; GYNECOMASTIA; HOT FLUSH; HUMAN; LIFESTYLE; MOOD DISORDER; MYOPATHY; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; OSTEOPOROSIS; PERIPHERAL NEUROPATHY; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; SMOKING CESSATION; SPINE FRACTURE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; HEALTH SERVICES FOR THE AGED; HEALTH STATUS; HUMANS; LIFE STYLE; NEOPLASMS; QUALITY OF LIFE; RADIATION INJURIES; SURVIVORS;

EID: 33750338802     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2006.06.003     Document Type: Review

References (126)

1. Office of Cancer Survivorship. Estimated US cancer prevalence counts: who are our cancer survivors in the US? (2005), National Cancer Institute. http://cancercontrol.cancer.gov/ocs/prevalence http://cancercontrol.cancer.gov/ocs/prevalence
2. Aziz N.M. Cancer survivorship research: challenge and opportunity. J Nutr 132 11 Suppl (2002) 3494S-3503S
3. Aziz N.M., and Rowland J.H. Cancer survivorship research among ethnic minority and medically underserved groups. Oncol Nurs Forum 29 5 (2002) 789-801
4. Hewitt M., Rowland J.H., and Yancik R. Cancer survivors in the United States: age, health, and disability. J Gerontol Biol Sci Med Sci 58 1 (2003) 82-91
5. Jemal A., Clegg L.X., Ward E., et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 101 1 (2004) 3-27
6. Mullan F. Seasons of survival: reflections of a physician with cancer. N Engl J Med 313 4 (1985) 270-273
7. Brenner H., and Arndt V. Recent increase in cancer survival according to age: higher survival in all age groups, but widening age gradient. Cancer Causes Control 15 9 (2004) 903-910
8. Aziz N.M., and Rowland J.H. Trends and advances in cancer survivorship research: challenge and opportunity. Semin Radiat Oncol 13 3 (2003) 248-266
9. Golematis B.C., Delikaris P.G., Balarutsos C., and Karamanakos P.P. Lymphedema of the upper limb after surgery for breast cancer. Am J Surg 129 3 (1975) 286-288
10. Pezner R.D., Patterson M.P., Hill L.R., et al. Arm lymphedema in patients treated conservatively for breast cancer: relationship to patient age and axillary node dissection technique. Int J Radiat Oncol Biol Phys 12 12 (1986) 2079-2083
11. Geller B.M., Vacek P.M., O'Brien P., and Secker-Walker R.H. Factors associated with arm swelling after breast cancer surgery. J Womens Health 12 9 (2003) 921-930
12. Kessler T.M., Burkhard F.C., Perimenis P., et al. Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution. J Urol 172 4 Pt 1 (2004) 1323-1327
13. Noh C., Kshirsagar A., and Mohler J.L. Outcomes after radical retropubic prostatectomy. Urology 61 2 (2003) 412-416
14. Raina R., Lakin M.M., Agarwal M.A., et al. Efficacy and factors associated with successful outcome of sildenafil citrate use for erectile dysfunction after radical prostatectomy. Urology 63 5 (2004) 960-966
15. Schover L.R., Fouladi R.T., Warneke C.L., et al. Defining sexual outcomes after treatment for localized prostate carcinoma. Cancer 95 8 (2002) 1773-1785
16. Talcott J.A., Rieker P., Clark J.A., et al. Patient-reported symptoms after primary therapy for early prostate cancer: Results of a prospective cohort study. J Clin Oncol 16 1 (1998) 275-283
17. Van der Aa F., Joniau S., De Ridder D., and Van Poppel H. Potency after unilateral nerve sparing surgery: a report on functional and oncological results of unilateral nerve sparing surgery. Pros Cancer Prost Dis 6 1 (2003) 61-65
18. Zagaja G.P., Mhoon D.A., Aikens J.E., and Brendler C.B. Sildenafil in the treatment of erectile dysfunction after radical prostatectomy. Urology 56 4 (2000) 631-634
19. Selli C., De Antoni P., Moro U., Macchiarella A., Giannarini G., and Crisci A. Role of bladder neck preservation in urinary continence following radical retropubic prostatectomy. Scand J Urol Nephrol 38 1 (2004) 32-37
20. DiCarlo V., Balzano G., Zerbi A., and Villa E. Pancreatic cancer resection in elderly patients. Br J Surg 85 5 (1998) 607-610
21. Fong Y., Blumgart L.H., Fortner J.G., and Brennan M.F. Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg 222 4 (1995) 426-434
22. Saltzstein S.L., and Behling C.A. Five- and 10-year survival in cancer patients aged 90 and older: a study of 37,318 patients from SEER. J Surg Oncol 81 3 (2002) 113-116
23. Balducci L. Geriatric oncology. Crit Rev Oncol Hematol 46 3 (2003) 211-220
24. Wildiers H., Highley M.S., de Bruijn E.A., and van Oosterom A.T. Pharmacology of anticancer drugs in the elderly population. Clin Pharmacokinet 42 14 (2003) 1213-1242
25. Begg C.B., and Carbone P.P. Clinical trials and drug toxicity in the elderly. The experience of the Eastern Cooperative Oncology Group. Cancer 52 11 (1983) 1986-1992
26. Pinto A., De Filippi R., Frigeri F., Corazzelli G., and Normanno N. Aging and the hemopoietic system. Crit Rev Oncol Hematol 48 Suppl (2003) S3-S12
27. Lichtman S.M., Skirvin J.A., and Vemulapalli S. Pharmacology of antineoplastic agents in older cancer patients. Crit Rev Oncol Hematol 46 2 (2003) 101-114
28. Chu E., and DeVita V.T. Physicians' cancer chemotherapy drug manual (2005), Jones Bartlett
29. Dowsett M. Origin and characteristics of adverse events in aromatase inhibition therapy for breast cancer. Semin Oncol 30 4 Suppl 14 (2003) 58-69
30. Cummings F.J. Evolving uses of hormonal agents for breast cancer therapy. Clin Ther 24 Suppl C (2002) C3-C25
31. Gradishar W. Fulvestrant in the treatment of postmenopausal women with advanced breast cancer. Exp Rev Anticancer Ther 5 3 (2005) 445-453
32. Higano C.S. Side effects of androgen deprivation therapy: monitoring and minimizing toxicity. Urology 61 2 Suppl 1 (2003) 32-38
33. Hedlund P.O., and Henriksson P. Parenteral estrogen versus total androgen ablation in the treatment of advanced prostate carcinoma: effects on overall survival and cardiovascular mortality. The Scandinavian Prostatic Cancer Group (SPCG)-5 Trial Study. Urology 55 3 (2000) 328-333
34. Kanard A.S., Frytak S., and Jatoi A. Cognitive dysfunction in patients with small-cell lung cancer: incidence, causes, and suggestions on management. J Support Oncol 2 2 (2004) 127-132
35. Wilder R.B., Chou R.H., Ryu J.K., et al. Potency preservation after three- dimensional conformal radiotherapy for prostate cancer: preliminary results. Am J Clin Oncol 23 4 (2000) 330-333
36. Bines J., and Gradishar W.J. Primary care issues for the breast cancer survivor. Compr Ther 23 9 (1997) 605-611
37. Brown B.W., Brauner C., and Minnotte M.C. Non-cancer deaths in white adult cancer patients. J Natl Cancer Inst 85 12 (1993) 979-987
38. Li F.P., and Stovall E.L. Long-term survivors of cancer. Cancer Epidemiol Biomarkers Prevent 7 4 (1998) 269-270
39. Newschaffer C.J., Otani K., McDonald M.K., and Penberthy L.T. Causes of death in elderly prostate cancer patients and in a comparison non-prostate cancer cohort. J Natl Cancer Inst 92 8 (2000) 613-621
40. Talamini R., Franceschi S., Favero A., Negri E., Parazzini F., and La Vecchia C. Selected medical conditions and risk of breast cancer. Br J Cancer 75 11 (1997) 1699-1703
41. Wingo P.A., Ries L.A., Parker S.L., and Heath Jr. C.W. Long-term cancer patient survival in the United States. Cancer Epidemiol Biomarkers Prevent 7 4 (1998) 271-282
42. Yabroff K.R., Lawrence W.F., Clauser S., Davis W.W., and Brown M.L. Burden of illness in cancer survivors: Findings from a population-based national sample. J Natl Cancer Inst 96 17 (2004) 1322-1330
43. Twiss J.J., Waltman N., Ott C.D., Gross G.J., Lindsey A.M., and Moore T.E. Bone mineral density in postmenopausal breast cancer survivors. J Am Acad Nurse Pract 13 6 (2001) 276-284
44. Nagi S. Disability concepts revisited: implications for prevention. Disability in America: toward a national agenda for prevention (1991), National Academy Press, Washington, DC p. 1309-27
45. Baker F., Haffer S.C., and Denniston M. Health-related quality of life of cancer and non-cancer patients in Medicare managed care. Cancer 97 3 (2003) 674-681
46. Chirikos T.N., Russell-Jacobs A., and Jacobsen P.B. Functional impairment and the economic consequences of female breast cancer. Women Health 36 1 (2002) 1-20
47. Ashing-Giwa K., Ganz P.A., and Petersen L. Quality of life of African-American and white long term breast carcinoma survivors. Cancer 85 2 (1999) 418-426
48. Broeckel J.A., Jacobsen P.B., Balducci L., Horton J., and Lyman G.H. Quality of life after adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat 62 2 (2000) 141-150
49. Goodwin J.S., Samet J.M., and Hunt W.C. Determinants of survival in older cancer patients. J Natl Cancer Inst 88 15 (1996) 1031-1038
50. Mandelblatt J.S., Edge S.B., Meropol N.J., et al. Predictors of long-term outcomes in older breast cancer survivors: perceptions versus patterns of care. J Clin Oncol 21 5 (2003) 855-863
51. Silliman R.A., Prout M.N., Field T., Kalish S.C., and Colton T. Risk factors for a decline in upper body function following treatment for early stage breast cancer. Breast Cancer Res Treat 54 1 (1999) 25-30
52. Williams M.E., and Evans J. Caring for our future selves. Am J Med 117 7 (2004) 537-540
53. Satariano W.A., Ragland D.R., and DeLorenze G.N. Limitations in upper-body strength associated with breast cancer: a comparison of black and white women. J Clin Epidemiol 49 5 (1996) 535-544
54. Garman K.S., Pieper C.F., Seo P.H., and Cohen H.J. Function in elderly cancer survivors depends on comorbidities. J Gerontol Biol Sci Med Sci 58 12 (2003) M1119-M1124
55. Schroevers M.J., Ranchor A.V., and Sanderman R. The role of age at the onset of cancer in relation to survivors' long-term adjustment: a controlled comparison over an eight-year period. Psycho-Oncology 13 10 (2004) 740-752
56. Fine J.T., Colditz G.A., Coakley E.H., et al. A prospective study of weight change and health-related quality of life in women. JAMA 282 22 (1999) 2136-2142
57. Sutton L.M., Demark-Wahnefried W., and Clipp E.C. Management of terminal cancer in elderly patients. Lancet Oncol 4 3 (2003) 149-157
58. Brown J.K., Byers T., Doyle C., et al. Nutrition and physical activity during and after cancer treatment: an American cancer society guide for informed choices. CA Cancer J Clin 53 5 (2003) 268-291
59. Chlebowski R.T., Aiello E., and McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol 20 4 (2002) 1128-1143
60. Demark-Wahnefried W., Winer E.P., and Rimer B.K. Why women gain weight with adjuvant chemotherapy for breast cancer. J Clin Oncol 11 7 (1993) 1418-1429
61. Demark-Wahnefried W., Aziz N.M., Rowland J.H., and Pinto B.M. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 23 24 (2005) 5805-5813
62. Nordevang E., Callmer E., Marmur A., and Holm L.E. Dietary intervention in breast cancer patients: effects on food choice. Eur J Clin Nutr 46 6 (1992) 387-396
63. Rock C.L., and Demark-Wahnefried W. Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol 20 15 (2002) 3302-3316
64. Bergstrom A., Pisani P., Tenet V., Wolk A., and Adami H.O. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 91 3 (2001) 421-430
65. World Health Organization. IARC Handbook of Cancer Prevention (ISSN 1027-5622); vol. 6. 2002.
66. Amling C.L. The association between obesity and the progression of prostate and renal cell carcinoma. Urol Oncol 22 6 (2004) 478-484
67. Amling C.L., Riffenburgh R.H., Sun L., et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 22 3 (2004) 439-445
68. Freedland S.J., Aronson W.J., Kane C.J., et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the shared equal access regional cancer hospital database study group. J Clin Oncol 22 3 (2004) 446-453
69. Freedland S.J., Terris M.K., Presti Jr. J.C., et al. Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins. J Urol 172 2 (2004) 520-524
70. Kroenke C.H., Chen W.Y., Rosner B., and Holmes M.D. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 23 7 (2005) 1370-1378
71. Demark-Wahnefried W., Peterson B., McBride C., Lipkus I., and Clipp E. Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. Cancer 88 3 (2000) 674-684
72. Massie M.J. Prevalence of depression in patients with cancer. Monogr J Natl Cancer Inst 32 (2004) 57-71
73. Rao A., and Cohen H.J. Symptom management in the elderly cancer patient: fatigue, pain, and depression. Monogr J Natl Cancer Inst 32 (2004) 150-157
74. Deimling GT, Bowman KF, Sterns S, Wagner LJ, Kahana B. Cancer-related health worries and psychological distress among older adult, long-term cancer survivors. Psycho-oncology, 25 July 2005 [Epub ahead of print].
75. Edwards B., and Clarke V. The psychological impact of a cancer diagnosis on families: the influence of family functioning and patients' illness characteristics on depression and anxiety. Psycho-Oncology 13 8 (2004) 562-576
76. Respini D., Jacobsen P.B., Thors C., Tralongo P., and Balducci L. The prevalence and correlates of fatigue in older cancer patients. Crit Rev Oncol Hematol 47 3 (2003) 273-279
77. Gotay C.C., and Muraoka M.Y. Quality of life in long-term survivors of adult-onset cancers. J Natl Cancer Inst 90 9 (1998) 656-667
78. Bush N.E., Haberman M., Donaldson G., and Sullivan K.M. Quality of life of 125 adults surviving 6-18 years after bone marrow transplantation. Soc Sci Med 40 4 (1995) 479-490
79. Omne-Ponten M., Holmberg L., and Sjoden P.O. Psychosocial adjustment among women with breast cancer stages I and II: 6-year follow-up of consecutive patients. J Clin Oncol 12 9 (1994) 1778-1782
80. Vinokur A.D., Threatt B.A., Caplan R.D., and Zimmerman B.L. Physical and psychosocial functioning and adjustment to breast cancer. Long-term follow-up of a screening population. Cancer 63 2 (1989) 394-405
81. Kattlove H., and Winn R.J. Ongoing care of patients after primary treatment for their cancer. CA-Cancer J Clin 53 3 (2003) 172-196
82. McCarthy N.J. Care of the breast cancer survivor: Increased survival rates present a new set of challenges. Postgrad Med 116 4 (2004) 39-40
83. Ganz P.A., Desmond K.A., Leedham B., Rowland J.H., Meyerowitz B.E., and Belin T.R. Quality of life in long-term, disease-free survivors of breast cancer: a follow- up study. J Natl Cancer Inst 94 1 (2002) 39-49
84. Gritz E.R., Nisenbaum R., Elashoff R.E., and Holmes E.C. Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer. CA-Cancer J Clin 2 2 (1991) 105-112
85. Narsavage G., and Romeo E. Education and support needs of younger and older cancer survivors. Appl Nurs Res 16 2 (2003) 103-109
86. Hewitt M., and Rowland J.H. Mental health service use among adult cancer survivors: analyses of the National health interview survey. J Clin Oncol 20 23 (2002) 4581-4590
87. Rojas M.P., Telaro E., Russo A., et al. Follow-up startegies for women treated for early breast cancer. Cochrane Database Syst Rev 4 (2000) CD001768
88. American Society of Clinical Oncology policy statement update: genetic testing for cancer, susceptibility. J. Clin Oncol 21 12 (2003) 2397-2406
89. Bast Jr. R.C., Ravdin P., Hayes D.F., et al. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of clinical oncology. J Clin Oncol 19 6 (2001) 1865-1878
90. Benson III A.B., Desch C.E., Flynn P.J., et al. 2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol 18 20 (2000) 3586-3588
91. http://www.nccn.org/professionals/physicians Clinical Practice Guidelines in Oncology; 2005 Version 1.
92. Smith T.J., Davidson N.E., Schapira D.V., et al. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol 17 3 (1999) 1080-1082
93. Nayfield S.G., Karp J.E., Ford L.G., Dorr F.A., and Kramer B.S. Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst 83 20 (1991) 1450-1459
94. Martino S., Cauley J.A., Barrett-Connor E., et al. Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. J Natl Cancer Inst 96 23 (2004) 1751-1761
95. Hortobagyi G.N., Kau S.W., Buzdar A.U., et al. What is the prognosis of patients with operable breast cancer 5 years after diagnosis?. Annual Meeting Proceedings of the American Society of Clinical Oncology, vol. 23 (2004) [abstract #585]
96. Buzdar A.U. Data from the arimidex, tamoxifen, alone or in combination (ATAC) trial: implications for use of aromatase inhibitors in 2003. Clin Cancer Res 10 1 Pt 2 (2004) 355S-361S
97. Virtamo J., Pietinen P., Huttunen J.K., et al. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA 290 4 (2003) 476-485
98. Hong W.K., Spitz M.R., and Lippman S.M. Cancer chemoprevention in the 21st century: genetics, risk modeling, and molecular targets. J Clin Oncol 18 21 Suppl (2000) 9S-18S
99. Dresler C.M., Bailey M., Roper C.R., Patterson G.A., and Cooper J.D. Smoking cessation and lung cancer resection. Chest 110 5 (1996) 1199-1202
100. Gritz E.R., Schacherer C., Koehly L., Nielsen I.R., and Abemayor E. Smoking withdrawal and relapse in head and neck cancer patients. Head Neck 21 5 (1999) 420-427
101. Ostroff J.S., Jacobsen P.B., Moadel A.B., et al. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer 75 2 (1995) 569-576
102. McBride C.M., and Ostroff J.S. Teachable moments for promoting smoking cessation: the context of cancer care and survivorship. Cancer Control 10 4 (2003) 325-333
103. Demark-Wahnefried W., Morey M.C., Pieper C.F., Sloane R., Snyder D.C., and Cohen H.J. Physical function and associations with diet and exercise: results of a cross-sectional survey among elders with breast or prostate cancer. Int J Behav Nutr Phys Act 1 1 (2004) 16
104. Courneya K.S., Vallance J.K., McNeely M.L., Karvinen K.H., Peddle C.J., and Mackey J.R. Exercise issues in older cancer survivors. Crit Rev Oncol Hematol 51 3 (2004) 249-261
105. Holmes M.D., Chen W.Y., Feskanich D., Kroenke C.H., and Colditz G.A. Physical activity and survival after breast cancer diagnosis. JAMA 293 20 (2005) 2479-2486
106. de Waard F., Ramlau R., Mulders Y., de Vries T., and van Waveren S. A feasibility study on weight reduction in obese postmenopausal breast cancer patients. Eu J Cancer Prevent 2 3 (1993) 233-238
107. Djuric Z., DiLaura N.M., Jenkins I., et al. Combining weight-loss counseling with the weight watchers plan for obese breast cancer survivors. Obes Res 10 7 (2002) 657-665
108. Loprinzi C.L., Athmann L.M., Kardinal C.G., et al. Randomized trial of dietician counseling to try to prevent weight gain associated with breast cancer adjuvant chemotherapy. Oncology 53 3 (1996) 228-232
109. Boyar A.P., Rose D.P., Loughridge J.R., et al. Response to a diet low in total fat in women with postmenopausal breast cancer: a pilot study. Nutr Cancer 11 2 (1988) 93-99
110. Chlebowski R.T., Rose D., Buzzard I.M., et al. Adjuvant dietary fat intake reduction in postmenopausal breast cancer patient management. The Women's Intervention Nutrition Study (WINS). Breast Cancer Res Treat 20 2 (1992) 73-84
111. Kristal A.R., Shattuck A.L., Bowen D.J., Sponzo R.W., and Nixon D.W. Feasibility of using volunteer research staff to deliver and evaluate a low-fat dietary intervention: the American Cancer Society Breast Cancer Dietary Intervention Project. Cancer Epidemiol Biomarkers Prevent 6 6 (1997) 459-467
112. Rose D.P., Connolly J.M., Chlebowski R.T., Buzzard I.M., and Wynder E.L. The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients. Breast Cancer Res Treat 27 3 (1993) 253-262
113. Hebert J.R., Ebbeling C.B., Olendzki B.C., et al. Change in women's diet and body mass following intensive intervention for early-stage breast cancer. J Am Diet Assoc 101 4 (2001) 421-431
114. Pierce J.P., Faerber S., Wright F.A., et al. Feasibility of a randomized trial of a high-vegetable diet to prevent breast cancer recurrence. Nutr Cancer 28 3 (1997) 282-288
115. Pierce J.P., Newman V.A., Flatt S.W., et al. Telephone counseling intervention increases intakes of micronutrient- and phytochemical-rich vegetables, fruit and fiber in breast cancer survivors. J Nutr 134 2 (2004) 452-458
116. Chlebowski R.T., Blackburn G.L., Elashoff R.E., et al. The WINS Investigators. Dietary fat reduction in postmenopausal women with primary breast cancer: Phase III Women's Intervention Nutrition Study (WINS). Annual Meeting Proc Am Soc Clin Oncol, vol. 24 (2005) [abstract #10]
117. Demark-Wahnefried W., Clipp E.C., Morey M.C., et al. A lifestyle intervention development study to improve physical function in older adults with cancer: outcomes from project lead (leading the way in exercise and diet). J Clin Oncol 24 21 (2006)
118. McDougall Jr. G.J. Memory improvement program for elderly cancer survivors. Geriatric Nurs 22 4 (2001) 185-190
119. Earle C.C., Burstein H.J., Winer E.P., and Weeks J.C. Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol 21 8 (2003) 1447-1451
120. Smith R.A., Cokkinides V., and Eyre H.J. American cancer society guidelines for the early detection of cancer. CA Cancer J Clin 55 1 (2005) 31-44
121. Optimal Calcium Intake: NIH consensus statement. 1994;12:1-31.
122. Anonymous. Statement on use of apolipoprotein E testing for Alzheimer disease. American College of Medical Genetics/American Society of Human Genetics Working group on ApoE and Alzheimer disease. JAMA 274 20 (1995) 1627-1629
123. US Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd Ed. 1996 ed. (1989), Williams and Wilkins, Baltimore
124. Goldberg T.H., and Chavin S.I. Preventive medicine and screening in older adults. J Am Geriatr Soc 45 3 (1997) 344-354
125. Pearson T.A., Blair S.N., Daniels S.R., et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 106 3 (2002) 388-391
126. Sullivan K.M., Dykewicz C.A., Longworth D.L., et al. Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. Hematology (2001) 392-421